Healthcare -
Biotechnology - NASDAQ - US
$ 2.69
2.67 %
$ 3.88 M
Market Cap
-0.52
P/E
SLRX - COST OF REVENUE
Cost of Revenue SLRX - Salarius Pharmaceuticals, Inc.
10.1 K
LAST VALUE
-27.62%
2 YEAR CAGR
-52.84%
5 YEAR CAGR
0.00%
10 YEAR CAGR